The effect of risk factors on surgical and oncological results in high-risk prostate cancer: A multicentre study of the urooncology society, Turkey

被引:1
作者
Izol, Volkan [1 ]
Akdogan, Nebil [1 ]
Ozen, Haluk [2 ]
Akdogan, Bulent [2 ]
Kural, Ali Riza [3 ]
Tuna, Mustafa Bilal [3 ]
Sozen, Sinan [4 ]
Turkeri, Levent [5 ]
Tansug, Mustafa Zuhtu [1 ]
机构
[1] Cukurova Univ, Fac Med, Dept Urol, TR-01330 Adana, Turkey
[2] Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey
[3] Acibadem Univ, Acibadem Maslak Hosp, Dept Urol, Istanbul, Turkey
[4] Gazi Univ, Fac Med, Dept Urol, Ankara, Turkey
[5] Acibadem Univ, Altunizade Hosp, Dept Urol, Istanbul, Turkey
关键词
RADICAL PROSTATECTOMY; SURVIVAL; MORTALITY; THERAPY; OUTCOMES; IMPACT; MEN;
D O I
10.1111/ijcp.14281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose To evaluate the effect of risk factors and selected surgical methods on operative and oncological results of patients undergoing radical prostatectomy (RP) with high-risk prostate cancer (HRPC). Methods Retrospective analysis of patients who underwent RP for HRPC from 13 urology centres between 1990 and 2019 was performed. Groups were created according to the risk factors of D'Amico classification. Patients with one risk factor were included in group 1 where group 2 consisted of patients with two or three risk factors. Results A total of 1519 patients were included in this study and 1073 (70.6%) patients were assigned to group 1 and 446 (29.4%) patients to group 2. Overall (biochemical and/or clinical and/or radiological) progression rate was 12.4% in group 1 and 26.5% in group 2 (P = .001). Surgical procedure was open RP in 844 (55.6%) patients and minimally invasive RP in 675 (44.4%) patients (laparoscopic and robot-assisted RP in 230 (15.1%) and 445 (29.3%) patients, respectively). Progression rates were similar in different types of operations (P = .22). Progression rate was not significantly different in patients who either underwent pelvic lymph node dissection (PLND) or not in each respective group. Conclusion RP alone is an effective treatment in the majority of patients with HRPC and PLND did not affect the progression rates after RP. According to the number of pre-operative high-risk features, as the number of risk factors increases, there is a need for additional treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Are the Recommended Criteria for Clinically Insignificant Prostate Cancer Applicable to 12-core Prostate Biopsy Scheme? A Multicentre Study of Urooncology Association, Turkey
    Celik, Serdar
    Kizilay, Fuat
    Yorukoglu, Kutsal
    Ozen, Haluk
    Akdogan, Bulent
    Izol, Volkan
    Bayazit, Yildirim
    Aslan, Guven
    Sozen, Sinan
    Baltaci, Sumer
    Muezzinoglu, Talha
    Narter, Fehmi
    Turkeri, Levent
    UROONKOLOJI BULTENI-BULLETIN OF UROONCOLOGY, 2021, 20 (01): : 19 - 25
  • [22] High-risk prostate cancer: treat the prostate
    Cooperberg, Matthew R.
    LANCET, 2011, 378 (9809) : 2056 - 2057
  • [23] Definition of high-risk prostate cancer impacts oncological outcomes after radical prostatectomy
    Knipper, Sophie
    Karakiewicz, Pierre I.
    Heinze, Alexander
    Preisser, Felix
    Steuber, Thomas
    Huland, Hartwig
    Graefen, Markus
    Tilki, Derya
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2020, 38 (04) : 184 - 190
  • [24] Neoadjuvant therapies for surgical management of high-risk, localized prostate cancer
    Mikkilineni, Nina
    Hyams, Elias S.
    TRANSLATIONAL CANCER RESEARCH, 2018, 7 : S662 - S675
  • [25] Comparison of the effectiveness of radiation and surgical treatment methods in high and very high risk prostate cancer
    Novikov, S. N.
    Samartseva, E. E.
    Novikov, R. V.
    Nosov, A. K.
    Protsenko, S. A.
    Buevich, N. N.
    Petrov, S. B.
    Ilyin, N. D.
    Merezhko, Yu. O.
    Antipov, F. E.
    Kanaev, S. V.
    ONKOUROLOGIYA, 2024, 19 (02): : 44 - 54
  • [26] Discord Among Radiation Oncologists and Urologists in the Postoperative Management of High-Risk Prostate Cancer
    Kishan, Amar U.
    Duchesne, Gillian
    Wang, Pin-Chieh
    Rwigema, Jean-Claude M.
    Kishan, Arun U.
    Saigal, Christopher
    Rettig, Matthew
    Steinberg, Michael L.
    King, Christopher R.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (08): : 739 - 746
  • [27] Novel Prognostic Index of High-Risk Prostate Cancer Using Simple Summation of Very High-Risk Factors
    Yamazaki, Hideya
    Suzuki, Gen
    Masui, Koji
    Aibe, Norihiro
    Shimizu, Daisuke
    Kimoto, Takuya
    Yamada, Kei
    Shiraishi, Takumi
    Fujihara, Atsuko
    Okihara, Koji
    Yoshida, Ken
    Nakamura, Satoaki
    Okabe, Haruumi
    CANCERS, 2021, 13 (14)
  • [28] High-risk prostate cancer: the role of radical prostatectomy for local therapy
    Ghavamian, Reza
    Williams, Steve K.
    Hakimi, A. Ari
    FUTURE ONCOLOGY, 2011, 7 (04) : 543 - 550
  • [29] Role of surgery in high-risk localized prostate cancer
    Lawrentschuk, N.
    Trottier, G.
    Kuk, C.
    Zlotta, A. R.
    CURRENT ONCOLOGY, 2010, 17 : S25 - S32
  • [30] Radical prostatectomy for high-risk prostate cancer | Opinion: NO
    Ghodoussipour, Saum
    Cacciamani, Giovanni Enrico
    de Castro Abreu, Andre Luis
    INTERNATIONAL BRAZ J UROL, 2019, 45 (03): : 428 - 434